Company Financials

Royalty Pharma plc Financials

United States dollar

business Royalty Pharma plc Company Profile

Main Stock Listing

NASDAQ: RPRX

Market Capitalization $20.45 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 14.84
Forward PE 8.28
Price to Sales TTM $9.03
Price to Book MRQ $2.31
Enterprise to Revenue 10.96
Enterprise to EBITDA 18.13

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 48.26%
Operating Margin 94.00%
Return on Assets TTM 7.04%
Return on Equity TTM 18.00%

Income Statement

Revenue TTM $2,263,845,120
Revenue per Share TTM $5.09
Quarterly Revenue Growth -4.28%
Gross Profit TTM $2,242,124,032
EBITDA $2,000,914,000
Net Income to Common TTM $1,092,553,984
Diluted EPS TTM $2.45
Quarterly Earnings Growth YoY 4888.50%

Balance Sheet

Total Cash MRQ $1,099,820,032
Total Cash per Share MRQ $2.61
Total Debt MRQ $
Total Debt to Equity MRQ 77.82
Current Ratio MRQ 1.56
Book Value per Share MRQ $15.72

Cash Flow

Operating Cash Flow TTM $2,700,423,936
Levered Free Cash Flow TTM $-1,360,302,080

RPRX Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 445,985,000
Float Shares 368,395,938
Avg 10 Volume 4,009,060
Avg 30 Volume None
Shares Short 29,032,462
Short Ratio 4.98
Short % of Shares 7.00%
% Held by Insiders 8.92%
% Held by Institutions 79.64%

Stock Price Summary

Beta 0.47
Fifty Two Week Low $24.05
Fifty Two Week High $36.43
Fifty Two Week Change 29.42%
Day 50 MA $33.72
Day 200 MA $30.35

Dividends and Splits

Forward Annual Dividend Rate $0.88
Forward Annual Dividend Yield 2.42%
Trailing Annual Dividend Rate $0.86
Trailing Annual Dividend Yield 2.36%
Payout Ratio 34.69%
Dividend Date 2025-06-10
Ex Dividend Date 2025-05-16
Last Split Factor
Last Split Date